Kalit so‘zlar
Abstrak
The development of reperfusion syndrome following systemic thrombolytic therapy was associated with a progressive immunoinflammatory imbalance, manifested by a sequential increase in IL-6, IL-10, and the neutrophil-to-lymphocyte ratio (NLR). The findings suggest that the combination of a dynamic rise in IL-6 and NLR may serve as a potential laboratory marker for an adverse post-reperfusion course and outcome. Longitudinal monitoring of IL-6, IL-10, and NLR holds greater diagnostic and prognostic value than a single measurement taken at admission.
References
Ahn JH, Won MH. Special Issue: New Molecular Insights into Ischemia/Reperfusion. International Journal of Molecular Sciences. 2025; 26(1):212. https://doi.org/10.3390/ijms26010212
Anrather J., Iadecola C. Inflammation and Stroke: An Overview. Neurotherapeutics. 2016;13(4):661–670. DOI: 10.1007/s13311-016-0483-x .
Duan M., Xu Y., Li Y., et al. Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke. J Neuroinflammation. 2024;21:102. DOI: 10.1186/s12974-024-03101-y .
Duan W.L., Wang X.J., Ma Y.P., et al. Therapeutic strategies targeting the NLRP3-mediated inflammatory response and pyroptosis in cerebral ischemia/reperfusion injury. Mol Med Rep. 2024;29(3):46. DOI:10.3892/ mmr. 2024.13170 . PMID: 38275110.
Feigin V.L., Stark B.A., Johnson C.O., et al. Global, regional, and national burden of stroke and its risk factors, 1990–2021. Neurology. 2024;103(2):e209660. DOI: 10.1212/WNL.0000000000209660 .
Feigin VL, MozgM, Norrving B, Martins S, Sakko RL, Hacke V, et al. World Stroke Organization (WSO): global stroke update 2022. International Journal of Stroke. 2022; 17(1): 18–29.
Feigin VL, Owolabi MO; The Lancet Commission on Neurology Stroke Collaborating Group. Pragmatic solutions for reducing the global burden of stroke: a World Stroke Organization-Lancet Neurology commission. Lancet Neurol. 2023; 22(12): 1160–206.
Guo, S.; Liu, R.; Chen, S.; Liu, S.; Wu, J. Mechanisms and therapeutic targets of ischemia-reperfusion injury in stroke: a review article focusing on blood-brain barrier dysfunction. Brain Sci. 2026 , 16 , 469. https://doi.org/ 10.3390/ brainsci 16050469
He, J.; Liu, D.; Zhao, L.; Zhou, D.; Rong, J.; Zhang, L.; Xia, Z. Myocardial ischemia-reperfusion injury: Mechanisms of injury and implications for treatment. Experimental Internal Medicine, 2022 , 23 , 430
Jayaraj R.L., Azimullah S., Beiram R., et al. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16:142. DOI: 10.1186/s12974-019-1516-2 .
Jin L, Zhu Z, Hong L, Qian Z, Wang F, Mao Z. ROS-чувствительные полимерные наночастицы, конъюгированные с 18β-глицирретиновой кислотой, обеспечивают нейропротекцию при ишемическом инсульте посредством ингибирования HMGB1 и регуляции поляризации микроглии. Bioact Mater. 2023;19:38–49. 10.1016/j.bioactmat. 2022.03.040.
Jurcau A, Simion A. Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies. Int J Mol Sci. 2021 Dec 21;23(1):14. doi: 10.3390/ijms23010014. PMID: 35008440; PMCID: PMC8744548.
Kim J.Y., Park J., Chang J.Y., et al. Inflammation after ischemic stroke: the role of leukocytes and cytokines. Exp Neurobiol. 2020;29(2):109–125. DOI: 10.5607/en20020 .
Li J., Wang Z., Li J., et al. HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation. Transl Stroke Res. 2025;16(4):990–1015. DOI: 10.1007/s12975-024-01258-5 . PMID: 38740617.
Meng X, Zheng Z, Yang L, Yang C, Li X and Hao Y (2025) Dynamic mechanisms and targeted interventions in cerebral ischemia–reperfusion injury: pathological cascade from ischemia to reperfusion and promising therapeutic strategies. Front. Neurosci. 19:1649533. doi: 10.3389/fnins.2025.1649533
Naito, H.; Nojima, T.; Fujisaki, N.; Tsukahara, K.; Yamamoto, H.; Yamada, T.; Aokage, T.; Yumoto, T.; Osako, T.; Nakao, A. Therapeutic strategies for ischemia-reperfusion injury in emergency medicine. Acute Med Surg. 2020 , 7 , e501.
Powers W.J., Rabinstein A.A., Ackerson T., et al. 2021 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2021;52(7):e364–e467. DOI: 10.1161/STR.0000000000000375 .
Stoll G., Nieswandt B., Schuhmann M.K. Ischemia/reperfusion injury in acute human and experimental stroke: focus on thrombo-inflammatory mechanisms and treatments. Neurol Res Pract. 2024;6:57. DOI: 10.1186/s42466-024-00355-y .
Weiss A, Ding Y. Beyond Reperfusion: Adjunctive Therapies Targeting Inflammation, Edema, and Blood-Brain Barrier Dysfunction in Ischemic Stroke. Cerebrovasc Dis. 2026;55(2):292-301. doi: 10.1159/000547092.
Xiong Ya, Vakhlu AK, Fisher M. Advances in acute ischemic stroke therapy. Circ Res. 2022;130(8):1230–51.
Yang M, Liu B, Chen B, Shen Y and Liu G (2025) Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. Front. Pharmacol. 16:1613464. doi: 10.3389/fphar.2025.1613464
Yu S. P.JiangM. Q.ShimS. S.PourkhodadadS.WeiL. (2023). Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease. Mol. Neurodegener.18 (1), 43. 10.1186/s13024-023-00636-1
Yurkau, A.; Ardelean, I.A. Molecular pathophysiological mechanisms of ischemia-reperfusion injury after recanalization in acute ischemic stroke. Journal of Integrative Neuroscience. 2021 , 20 , 727–744.
Zeng J, Bao T, Yang Q, Zhu S, Wang S, Xiang W, Ge A, Zeng L, Ge J. Mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural plant components in microglia regulation: a review. Front Immunol. 2022;13:1047550. 10.3389/fimmu.2022.1047550
Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J, Gao F, Wang S, Tan R, Yuan J. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x.
Zhang, C.; Jia, M.; Wang, Y.; Wang, C.; Wu, J. Mechanisms of cell death in ischemia-reperfusion injury of the brain. Neurochem. Res. 2022 , 47 , 3525–3542.